Replies to post #134819 on Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

Really? I'm shocked by how high the stock price is. Seems to me 30 cents a share is about right. There is little evidence that A273 is efficacious and management has repeatedly failed over the last 2 years to meet any of its stated clinical trial objectives. Talk on this MB of a Biogen buyout is pure fantasy. The story keeps changing, history is erased on the website and the management regularly fails to communicate any real information. IMO, this company is a con and the shareholders are suckers. Hope is a poor way to invest.

[Ragnaroc]

Hey not making good on three promised trials to start this year then being indifferent to questions about why will suppress any stock price.